CEO of CombinatorRx
CombinatoRx, Incorporated is a biotechnology company that merged with Neuromed Pharmaceuticals, Inc.
Blueprint Medicines is a biotechnology company that is working to improve human health.
EQRx Inc is a biotechnology company. Its pipeline programs include two pre-registrational oncology assets that have shown assuring Phase 3 data (aumolertinib and sugemalimab), and multiple other clinical-stage programs.
Tango Therapeutics is a cancer Therapeutics, Immuno-Oncology.
REVOLUTION Medicines is a small Molecules founded in 2014.
Relay Therapeutics is a Cambridge, Massachusetts-based developer of an allosteric drug-discover platform that is intended to apply computational techniques to protein motion.